covid-19 pill

The U.N.-backed Medicines Patent Pool says that nearly three dozen companies worldwide will soon start making generic versions of Pfizer’s coronavirus pill

Pfizer and Merck’s COVID-19 pills that were supposed to be an important weapon against the pandemic in the U.S. are in short supply and have played little role in the fight against the omicron wave of infections.

Newly infected COVID-19 patients have two new treatment options that can be taken at home.

The Food and Drug Administration has approved Merck’s anti-viral COVID-19 pill molnupiravir for emergency use.

The Food and Drug Administration approved an emergency use authorization for the first oral antiviral treatment of COVID-19.

The drug from Pfizer, Paxlovid, is a faster, cheaper way to treat early COVID-19 infections, though initial supplies will be extremely limited.

The pill from drug maker Merck could become the first U.S. authorized at-home treatment for the coronavirus.

U.S. health advisers have endorsed an antiviral drug from Merck to treat COVID-19.

U.S. health officials say Merck’s experimental COVID-19 pill is effective but they raised questions about its safety during pregnancy.

An antiviral pill to treat COVID and reduce the risk of hospitalization and death in high-risk groups could be around the corner. Here’s why immunocompromised people have the most to gain.

The United Kingdom became the first country in the world to approve a potentially game-changing COVID-19 antiviral pill jointly developed by Merck and Ridgeback Biotherapeutics.